Century Therapeutics director Truitt reports no holdings

Century Therapeutics filed a Form 3 identifying Joseph Truitt as a director, with no insider trades or holdings reported.

Rhea-AI Filing Summary

Century Therapeutics, Inc. (IPSC) filed an initial statement of beneficial ownership on Form 3 for Joseph Truitt, who is identified as a director of the company. The filing does not list any equity transactions, holdings, or derivative positions for Truitt and includes a remark referencing an Exhibit 24 Power of Attorney.

Key Terms

Form 3, beneficial ownership, Power of Attorney

3 terms

Form 3 regulatory

"filed an initial statement of beneficial ownership on Form 3 for Joseph"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"filed an initial statement of beneficial ownership on Form 3 for Joseph"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Power of Attorney regulatory

"remarks referencing an Exhibit 24 Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IPSC’s new Form 3 filing report about Joseph Truitt?

The Form 3 for Century Therapeutics (IPSC) identifies Joseph Truitt as a director of the company. It reports no equity transactions, no beneficial ownership positions, and references an Exhibit 24 Power of Attorney in the remarks section.

Does the IPSC Form 3 for Joseph Truitt report any insider trades?

No. The Form 3 for Joseph Truitt at Century Therapeutics (IPSC) shows no reported buy, sell, acquisition, or disposition transactions, and the transaction summary counts for all such activity are zero.

Are any share holdings disclosed for Joseph Truitt in IPSC’s Form 3?

No share holdings are listed. The Form 3’s data show no holding entries and no derivative positions for Joseph Truitt, indicating that the filing does not disclose any specific number of Century Therapeutics shares or options held.

What role does Joseph Truitt have at Century Therapeutics (IPSC) according to the Form 3?

According to the Form 3, Joseph Truitt is a director of Century Therapeutics, Inc. (IPSC). He is not identified in the form as an officer or a ten percent owner of the company.

Is there any Rule 10b5-1 trading plan indicated in the IPSC Form 3?

No. The Form 3 data show the Rule 10b5-1 indicator as not provided for this filing, and there are no footnotes describing any trading plan or pre-arranged trading arrangement for Joseph Truitt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 05:48 PM EDT Accepted by SEC EDGAR 09/10/2026 - 05:47 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Truitt Joseph

(Last) (First) (Middle)

C/O CENTURY THERAPEUTICS, INC.

25 N 38TH STREET, 12TH FLOOR

(Street)

PHILADELPHIA PENNSYLVANIA 19104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/09/2026

3. Issuer Name and Ticker or Trading Symbol
Century Therapeutics, Inc. [ IPSC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Douglas Carr, Attorney-in-Fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)